Home
>>
Antibody Platform
>>
Phage Display Platform
>>
scFv Antibody Library Screening Services
Download Center
Quick Inquiry & Consultation
scFv Antibody Library Screening Services

scFv (single-chain variable fragment) has a molecular weight of approximately 25 kDa. It consists of the variable regions of an IgG's light chain (VL) and heavy chain (VH), connected by a flexible linker peptide. scFvs are primarily constructed from hybridoma cells, mouse spleen cells, and human B lymphocytes. They offer advantages including small size, high specificity, and strong affinity. Leveraging their small size, strong tissue penetration, efficient intracorporal clearance, and low immunogenicity, scFvs are widely used for disease diagnosis and therapy. Furthermore, scFvs can be expressed in various systems, such as mammalian cells, yeast cells, plant cells, and insect cells. Among these, the E. coli expression system enables rapid, large-scale scFv production.

The goal of scFv Antibody Library Screening is to isolate antibody fragments with affinity for the target antigen. Phage Display Library Screening is the most widely applied method for this purpose. The antigen is immobilized on polypropylene microplates. Through 3-5 rounds of panning, scFv-phage antibodies with weak binding are removed, while specific clones binding the antigen are retained. A larger Phage Library Size facilitates the isolation of scFvs with greater diversity and stronger affinity. For Phage Display, the ELISA method is employed to ultimately identify positive clones. For Yeast Display, the FACS method is used, where cells displaying recombinant antibody fragments are detected using labeled antigen.

图片2.png

The goal of scFv Antibody Library Screening is to isolate antibody fragments with affinity for the target antigen. Phage Display Library Screening is the most widely applied method for this purpose. The antigen is immobilized on polypropylene microplates. Through 3-5 rounds of panning, scFv-phage antibodies with weak binding are removed, while specific clones binding the antigen are retained. A larger Phage Library Size facilitates the isolation of scFvs with greater diversity and stronger affinity. For Phage Display, the ELISA method is employed to ultimately identify positive clones. For Yeast Display, the FACS method is used, where cells displaying recombinant antibody fragments are detected using labeled antigen.

scFv Antibody Library Screening Service Workflow

Step

Service Content

Timeline

Antibody Library Amplification

Retrieve an appropriate volume of the primary antibody library glycerol stock and culture it in 2×YT-AG medium for expansion.

1 day

Helper Phage Infection of E. coli TG1

Infect the primary scFv antibody library with M13KO7 helper phage.

1 day

Phage Supernatant Preparation

Following centrifugation, collect the phage supernatant.

1 day

Phage Precipitation and Titration

Precipitate phages using PEG/NaCl.

1 day

Panning and Titration

Perform 3-5 rounds of Bio-Panning; titrate the antibody library and calculate the Library Size.

1 week

Positive Clone Identification and Analysis

Prepare phage supernatants from positive clones, Analyze phage supernatants via ELISA, Verify positive clones from plates by PCR.

1 day

Advantages of scFv Antibody Library Screening Service

--Customized Personalized scFv Antibody Library Screening Solutions designed by professionals.

--Provision of scFv Antibody Library Screening Advice to optimize the screening process.

--Screening of scFv libraries characterized by high diversity and large library capacity.

--Acquisition of high-quality scFv phage clones post-screening, with high positive rate confirmed by PCR identification.

--Capability to screen for scFv with strong specificity as required by clients.

--Integrated services encompassing scFv Antibody Library Construction, Screening, and Antibody Expression.

--Offering Pre-made Libraries and Native Libraries, eliminating the need for animal immunization and significantly shortening experimental timelines.

--Capable of screening against various antigen formats, including proteins, peptides, toxins, and cells.

--Screening capability for Native Antibody Libraries, Immune Libraries, Synthetic Libraries, and Semi-Synthetic Libraries of scFv.

--No Requirement for cumbersome hybridoma fusion steps; the screening methodology is straightforward.

--Low Demands on the experimental environment, minimizing the risk of cross-contamination.

--Capability to screen scFv antibody libraries with large library capacity.

--Capability for Large-Scale scFv Antibody Expression via mammalian cells.

--ELISA-Based Screening Process that is operationally simple and features a short experimental cycle.

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now